• Info
  • Insider Ownership

Insider Trading & Ownership of Peter G. Traber

Location
Houston, TX
Summary
The estimated net worth of Peter G. Traber is at least $1,376,840 dollars as of 26 Sep 2023. Peter G. Traber is the Chief Medical Officer of SELECTA BIOSCIENCES INC and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $930.8K. Peter G. Traber is the Director of CALADRIUS BIOSCIENCES, INC. and owns shares of LISATA THERAPEUTICS, INC. (LSTA) stock worth about $446.1K.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Peter G. Traber and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sponsored

Quick Takeaways

  • Peter G. Traber has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,376,840.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: SELECTA BIOSCIENCES INC ($930,762).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Peter G. Traber

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNAC SELECTA BIOSCIENCES INC Chief Medical Officer $930,762 25 Sep 2023
LSTA CALADRIUS BIOSCIENCES, INC. Director $446,078 10 Jan 2022

Insider Transactions Reported by Peter G. Traber:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.